NextCure (NXTC) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

NXTC is expected to report earnings to fall 38.25% to -37 cents per share on August 01

NextCure NXTC Stock Earnings Reports
Q2'24
Est.
$-0.38
Q1'24
Missed
by $0.17
Q4'23
Est.
$-0.52
Q3'23
Beat
by $0.15
Q2'23
Missed
by $0.09
The last earnings report on May 02 showed earnings per share of -61 cents, missing the estimate of -43 cents. With 48.83K shares outstanding, the current market capitalization sits at 47.27M.
View a ticker or compare two or three
NXTC
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
82
Web
https://www.nextcure.com